Synapse

← JEADV Clinical Practice

Papers in JEADV Clinical Practice

Page 12 · newest first

  1. Prognostic factors in the primary care of patients with Merkel cell carcinoma: A monocentric cohort study of 108 patients from a tertiary referral centreJEADV Clinical Practice · 2023
  2. Bio‐experienced psoriasis patients treated with anti‐interleukin monoclonal antibodies are less likely to achieve PASI 90, PASI 100, PASI ≤ 1 and ≤3: Results from a cohort of 305 patientsJEADV Clinical Practice · 2023
  3. Unmet clinical needs, burden of disease and treatment patterns in hidradenitis suppurativa: Real‐world experience from SpainJEADV Clinical Practice · 2023
  4. Parvovirus in dermatology: A reviewJEADV Clinical Practice · 2023
  5. Perianal non‐septicaemic ecthyma gangrenosum caused by Klebsiella pneumoniaeJEADV Clinical Practice · 2023
  6. An infant with a unilateral facial flushJEADV Clinical Practice · 2023
  7. A comparative study of the image quality of dermoscopic images acquired in general practice versus at a dermatology departmentJEADV Clinical Practice · 2023
  8. Health utilities and health‐related quality of life of patients with keratinocyte skin cancersJEADV Clinical Practice · 2023
  9. D‐OCT‐assisted and histology‐controlled evaluation of 1064 nm Nd:YAG laser therapy of basal cell carcinomasJEADV Clinical Practice · 2023
  10. French dermatologists' opinions and practices with regard to adjuvant therapy in stage III melanomaJEADV Clinical Practice · 2023
  11. The impact of alcohol‐based hand sanitiser and hand washing with soap and water on bacterial skin microbiota compositionJEADV Clinical Practice · 2023
  12. Cutaneous leukocytoclastic vasculitis following COVID‐19 vaccinationJEADV Clinical Practice · 2023
  13. Reduced skin permeation and penetration of clobetasol propionate when Dermovate cream is applied at short time intervals with emollientsJEADV Clinical Practice · 2023
  14. Incidence of scabies in Michigan during the COVID‐19 pandemicJEADV Clinical Practice · 2023
  15. Efficacy and safety of abrocitinib in patients with moderate‐to‐severe atopic dermatitis with prior exposure to oral systemic immunosuppressants or biologic therapies: A post hoc analysis of the JADE clinical trialsJEADV Clinical Practice · 2023
  16. Intralesional and systemic rituximab in the treatment of primary cutaneous B‐cell lymphomaJEADV Clinical Practice · 2023
  17. Effect of abrocitinib and dupilumab on eosinophil levels in patients with moderate‐to‐severe atopic dermatitisJEADV Clinical Practice · 2023
  18. Artificial intelligence—An opportunity to optimise the care of acneic patientsJEADV Clinical Practice · 2023
  19. Biomarkers for disease progression identified in psoriasis patients: A pilot studyJEADV Clinical Practice · 2023
  20. HSP90: A potential drug target in inflammatory skin diseasesJEADV Clinical Practice · 2023
  21. Skin involvement in systemic lymphoma of follicular helper T‐cell origin: A cohort study of 57 patientsJEADV Clinical Practice · 2023
  22. A slowly growing, highly vascularized papule in a 4‐year‐old girlJEADV Clinical Practice · 2023
  23. Immunisation status during biologic therapy for hidradenitis suppurativa and psoriasisJEADV Clinical Practice · 2023
  24. Severe cutaneous scleromyxedema treated by lenalidomideJEADV Clinical Practice · 2023
  25. Primary cutaneous follicle centre lymphoma with secondary systemic evolutionJEADV Clinical Practice · 2023
  26. Long‐term secukinumab efficacy and safety in bio‐naïve patients with moderate‐to‐severe cutaneous psoriasis: A real‐world retrospective noninterventional multicentric experience (128 patients)JEADV Clinical Practice · 2023
  27. Assessing the burden of patients with psoriasis through the concept of cumulative life course impairment: A narrative literature reviewJEADV Clinical Practice · 2023
  28. Indolent adult T‐cell leukaemia‐lymphoma successfully treated with bexarotene in an eldery patientJEADV Clinical Practice · 2023
  29. Recalcitrant prurigo nodularis after COVID‐19 vaccination and successfully treated by dupilumabJEADV Clinical Practice · 2023
  30. Papular interstitial elastolytic giant cell granuloma concomitant with lichen amyloidosus in a type II diabetes patientJEADV Clinical Practice · 2023
  31. Reducing the treatment burden of keratinocyte cancers requiring referral to plastic surgery: Lessons from lockdownJEADV Clinical Practice · 2023
  32. Collaboration in the management of psoriasis and psoriatic arthritis: A survey of joint working in UK clinical practiceJEADV Clinical Practice · 2023
  33. Real‐world drug survival of Brodalumab, in patients with psoriasis switched from Ixekizumab: Results of a single centre retrospective study (BroSwitch)JEADV Clinical Practice · 2023
  34. Serum infliximab levels and clinical response in hidradenitis suppurativaJEADV Clinical Practice · 2023
  35. A systematic review of isotretinoin dosing in acne vulgarisJEADV Clinical Practice · 2023
  36. Focal vascular occlusion: A link between livedoid vasculopathy and cutaneous arteritis?JEADV Clinical Practice · 2023
  37. Pattern diagnosis of onycholysisJEADV Clinical Practice · 2023
  38. Physical activity and mental health among patients with atopic dermatitis or chronic spontaneous urticaria: A cross‐sectional studyJEADV Clinical Practice · 2023
  39. Dramatic deterioration or new‐onset dipeptidyl peptidase‐4 inhibitor‐associated bullous pemphigoid after COVID‐19 vaccination: A possible manifestation of immune reconstitution inflammatory syndromeJEADV Clinical Practice · 2023
  40. First experiences in real clinical practice treating a patient with generalised pustular psoriasis with SpesolimabJEADV Clinical Practice · 2023
  41. The association of hidradenitis suppurativa with obstructive sleep apnea: A cross‐sectional study using the All of Us databaseJEADV Clinical Practice · 2023
  42. A case of metallosis mimicking cutaneous malignant melanoma following total elbow arthroplastyJEADV Clinical Practice · 2023
  43. The genetic basis of pemphigus vulgarisJEADV Clinical Practice · 2023
  44. Lung adenocarcinoma presenting with eosinophilic erythroderma associated with anti‐KRT6B antibodies: Case reportJEADV Clinical Practice · 2023
  45. Out‐of‐pocket expenditures in adult patients with prurigo nodularis in FranceJEADV Clinical Practice · 2023
  46. Improvement in general touch avoidance in patients with moderate‐to‐severe genital psoriasis treated with ixekizumab during a 52‐week, randomized, phase 3 clinical trial (IXORA‐Q)JEADV Clinical Practice · 2023
  47. Assessment of flare frequency and severity of generalized pustular psoriasis in Japanese patients: A retrospective chart review studyJEADV Clinical Practice · 2023
  48. Sustainable patient education in hidradenitis suppurativaJEADV Clinical Practice · 2023
  49. Skin lesions on a man's face and scalpJEADV Clinical Practice · 2023
  50. Successful long‐term treatment of pyoderma gangrenosum with secukinumabJEADV Clinical Practice · 2023